DURECT Balance Sheet Health

Financial Health criteria checks 2/6

DURECT has a total shareholder equity of $1.2M and total debt of $10.5M, which brings its debt-to-equity ratio to 860%. Its total assets and total liabilities are $24.1M and $22.8M respectively.

Key information

860.0%

Debt to equity ratio

US$10.47m

Debt

Interest coverage ration/a
CashUS$10.38m
EquityUS$1.22m
Total liabilitiesUS$22.85m
Total assetsUS$24.07m

Recent financial health updates

Is DURECT (NASDAQ:DRRX) A Risky Investment?

May 12
Is DURECT (NASDAQ:DRRX) A Risky Investment?

Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Jan 08
Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Aug 05
Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Recent updates

Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts

Aug 08
Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts

Durect names ex-RBC Capital Markets executive as CFO

Jul 05

Is DURECT (NASDAQ:DRRX) A Risky Investment?

May 12
Is DURECT (NASDAQ:DRRX) A Risky Investment?

DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be

Mar 14
DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be

DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 10
DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Jan 08
Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Aug 05
Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Durect (DRRX) Investor Presentation - Slideshow

May 06

Durect EPS misses by $0.01, misses on revenue

May 04

DURECT prices ~$43M stock offering

Feb 04

DURECT surges after FDA approval for Posimir

Feb 02

Durect's DUR-928 fast track'd for alcoholic hepatitis in the U.S.

Dec 16

DURECT (DRRX) Investor Presentation - Slideshow

Oct 31

Financial Position Analysis

Short Term Liabilities: DRRX's short term assets ($14.4M) do not cover its short term liabilities ($20.2M).

Long Term Liabilities: DRRX's short term assets ($14.4M) exceed its long term liabilities ($2.6M).


Debt to Equity History and Analysis

Debt Level: DRRX's net debt to equity ratio (7.4%) is considered satisfactory.

Reducing Debt: DRRX's debt to equity ratio has increased from 95.2% to 860% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: DRRX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: DRRX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 17.3% each year


Discover healthy companies